A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction

Clinical trial NCT05224609 · COMPLETED

Trial details

NCT number: NCT05224609
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Hepatic Impairment Severe Hepatic Impairment Healthy Volunteers

Start date: 2022-04-28
Primary completion: 2024-08-13
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.